GC
ACOR

Guggenheim Capital’s Acorda Therapeutics ACOR Stock Holding History

Guggenheim Capital’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-693
Closed -$1.97M – 2670
2018
Q1 		$1.97M Sell
693
-75
-10% -$225K ﹤0.01% 1653
2017
Q4 		$1.98M Sell
768
-208
-21% -$591K ﹤0.01% 1677
2017
Q3 		$2.77M Buy
976
+108
+12% +$285K 0.01% 1436
2017
Q2 		$2.05M Buy
868
+162
+23% +$321K 0.01% 1603
2017
Q1 		$1.78M Sell
706
-53
-7% -$153K ﹤0.01% 1751
2016
Q4 		$1.71M Sell
759
-195
-20% -$464K ﹤0.01% 1800
2016
Q3 		$2.39M Sell
954
-44
-4% -$131K 0.01% 1502
2016
Q2 		$3.06M Sell
998
-44
-4% -$143K 0.01% 1287
2016
Q1 		$3.31M Sell
1,042
-148
-12% -$614K 0.01% 1234
2015
Q4 		$6.11M Sell
1,190
-413
-26% -$1.8M 0.02% 931
2015
Q3 		$5.1M Sell
1,603
-64
-4% -$248K 0.02% 1025
2015
Q2 		$6.67M Buy
1,667
+184
+12% +$711K 0.02% 1022
2015
Q1 		$5.92M Buy
1,483
+536
+57% +$2.45M 0.01% 1083
2014
Q4 		$4.64M Sell
947
-249
-21% -$1.07M 0.01% 1161
2014
Q3 		$4.86M Buy
1,196
+124
+12% +$465K 0.01% 1211
2014
Q2 		$4.34M Sell
1,072
-167
-13% -$681K 0.01% 1266
2014
Q1 		$5.64M Sell
1,239
-173
-12% -$699K 0.02% 1059
2013
Q4 		$4.95M Buy
1,412
+259
+22% +$1.01M 0.02% 1098
2013
Q3 		$4.75M Buy
1,153
+237
+26% +$1.02M 0.02% 1126
2013
Q2 		$3.63M Buy
+916
New +$3.77M 0.02% 1207

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Guggenheim Capital's ACOR Position: Q2 2018 in Review

Guggenheim Capital sold out of Acorda Therapeutics (ACOR) in Q2 2018, closing a stake of 693 shares — an estimated $1.97M sold.

Guggenheim Capital first reported a position in ACOR in Q2 2013 and held it in 20 quarters. The position peaked at $6.67M in Q2 2015. 175 funds tracked by Wall St. Rank hold ACOR as of Q2 2018.

  • Guggenheim Capital reported no remaining Acorda Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Guggenheim Capital sold 693 Acorda Therapeutics shares in Q2 2018, an estimated $1.97M.
  • Guggenheim Capital first reported a position in Acorda Therapeutics in Q2 2013 and held it in 20 quarters.
  • Guggenheim Capital's Acorda Therapeutics position peaked at $6.67M in Q2 2015.
  • 175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.